Cas:91446-15-0 4-Chloro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidine manufacturer & supplier

Chemical Name:4-Chloro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidine

CAS.NO:91446-15-0

Synonyms:1H-Pyrazolo[3,4-d]pyrimidine, 4-chloro-1-(tetrahydro-2H-pyran-2-yl)-;4-Chloro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-d]pyrimidine;4-chloro-1-(oxan-2-yl)pyrazolo[3,4-d]pyrimidine

Molecular Formula:C₁₀H₁₁ClN₄O

Molecular Weight:238.673

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:406.5±45.0 °C at 760 mmHg

Density:1.6±0.1 g/cm3

Index of Refraction:1.741

PSA:52.83000

Exact Mass:238.062134

LogP:0.28

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1H-Pyrazolo[3,4-d]pyrimidine, 4-chloro-1-(tetrahydro-2H-pyran-2-yl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-chloro-1-(oxan-2-yl)pyrazolo[3,4-d]pyrimidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Pyrazolo[3,4-d]pyrimidine, 4-chloro-1-(tetrahydro-2H-pyran-2-yl)- Use and application,1H-Pyrazolo[3,4-d]pyrimidine, 4-chloro-1-(tetrahydro-2H-pyran-2-yl)- technical grade,usp/ep/jp grade.

Related News: The use of the Spikevax vaccine in children from 12 to 17 years of age will be the same as in people aged 18 and above, EMA said. 2-chloro-N-((4-(1,1-dimethoxyethyl)-6-methylpyrimidin-2-yl)carbamoyl)benzenesulfonamide manufacturers The use of the Spikevax vaccine in children from 12 to 17 years of age will be the same as in people aged 18 and above, EMA said. 2-(3-benzyl-2-(phenylamino)-3,4-dihydroquinazolin-4-yl)acetamide suppliers This scheme also stipulates minimum domestic value addition in different target segments. Fermentation based products should have at least 90% and chemical synthesis based products should have at least 70% domestic content to qualify for the benefits. 4-Chloro-2-[2-(dimethylamino)-2-oxoethoxy]benzoic acid vendor & factory “It’s truly an important scientific issue and important public health issue and FDA is actively exploring all regulatory options for providing access to additional doses of authorized vaccines in situations where data suggests the benefits would outweigh the risks,” Fink said.,Defining the deliverables of the project in advance helps CDMOs to work through a realistic timeline that can work mutually for both parties.